🌟Ever found yourself doubting about IBD new drugs doses? or forgetting Thiopurine metabolism details? I've been there too So I thought it could help having "IBD Cheat Sheets" and that is what I did: ibd-eii.com/ibdcheatsheet I hope it helps as much as it helps me 1/2 #IBD

Don't miss out! #GEDII's annual meeting is underway! Packed with insightful discussions and exciting developments about IBD! Get in on the action until April 6th💥

It’s all about strategy ⁦GEDII⁩ annual congress. ⁩ ⁦Uri Kopylov⁩ ⁦⁦Vipul Jairath MBChB DPhil⁩ ⁦alessandro armuzzi⁩ ⁦GEDII⁩

Good luck to our colleagues in Portugal hosting what looks like a phenomenal IBD Congress with great lineup of local & international faculty 👏🤩 Fernando Magro Joana Torres Joana Roseira Paula Sousa Helena Tavares de Sousa Uri Kopylov alessandro armuzzi Manuel Barreiro Vipul Jairath MBChB DPhil

📢Day 2 of #GEDII2024 is here No drug like the first: Optimizing initial treatment for IBD alessandro armuzzi Tackling refractory IBD patients: New strategies for tough cases Vipul Jairath MBChB DPhil Balancing the tightrope: Finding the sweet spot between efficacy & safety #LaurentBeaugerie

Spotlight on the future! #GEDII2024 day 2 shines a light on the next generation of PT #IBD research. Young doctors & researchers are taking center stage with impactful oral comms, real-world clinical cases, and insightful posters. Witnessing the future of IBD care unfold!

Double duty at #GEDII2024! 🩺 Not only are top IBD docs diving deep into the latest research, but the IBD Nurse Course is also in full swing! Empowering nurses with the knowledge to deliver exceptional care.

New research - Chanchlani et al - Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn’s disease: 3-year data from the prospective, multicentre PANTS cohort study thelancet.com/journals/langa… #GITwitter #IBD

The PANTS-extension study out today The Lancet Gastroenterology & Hepatology After 3 years of therapy only 1/3 IFX and 1/3 ADA patients are still on drug in remission • notable that proportion exiting due to drug failure higher with ADA versus IFX (remember this is NOT randomised h2h) Most

What a honour to work with this fantastic team and to have our research Journal of Crohn's and Colitis The best way to finish my PhD thesis 🤩Fernando Magro #Fatima Carneiro irene gullo #Marta Ferreira # Ana Mafalda Rocha # Carla Oliveira

Fresh off the press! 📰 Can quantitative DWI assess inflammation & subsequent treatment response in Crohn's? Our very own Jonathan Dillman & colleagues address just that! doi.org/10.1007/s00261…

#GUTImages from the #RecentAdvancesInClinicalPractice paper by Florian Rieder et al entitled "Fibrosis in IBD: from pathogenesis to therapeutic targets" via bit.ly/4aLgTpO Cleveland Clinic MD Pranab Mukherjee #Fibrosis #IBD

Safety of lactation in women patients with #IBD and vaccination of infants born to mothers with IBD So much data to process throughout all this session with great content and summaries Fantastic Mette Julsgaard at Digestive Disease Week #DDW2024

VIVID-1 h2h trial with mirikizumab vs ustekinumab in #CD ✅mirikizumab achieved non-inferiority to ustekinumab ❗️Be aware this is not like SEQUENCE! Patients here were around 50% previously exposed to AntiTNF whereas SEQUENCE all were previously exposed and the trial design

Excellent overview on #perianal #crohnsdisease by Miguel F. Cunha

Huge honour for me to have you Dominik Bettenworth and Joana Torres as my PhD main jury. Unforgettable day! ❤️

🔬New paper from #WeTheFibrosisLab🔬Deciphering the Differences Between Stricturing With or Without Penetrating Crohn's Disease: One Step Closer to Solving the Puzzle ⁦Miguel Regueiro⁩ ⁦Fernando Magro⁩ ⁦Pranab Mukherjee⁩ ⁦Jyotsna Chandra, Ph.D.⁩ @ pubmed.ncbi.nlm.nih.gov/39074176/

THE RISK OF IBD IN OFFSPRING INCREASES IF EITHER PARENT HAS IBD BEFORE CHILDBIRTH 👩🏻👨🏾👶🏼 New Study in Gut shows that both maternal and paternal IBD diagnosis before childbirth is associated with higher IBD risk in offspring. Read the study here ➡️ gut.bmj.com/cgi/rapidpdf/g…

This is one of my favorite papers to assign for incoming graduate students. And, re-reading it for this morning's class gave me some reminders I needed myself. ✨ journals.biologists.com/jcs/article/12…

Risankizumab, IgG1, has lower than expected placental transfer rates with infant > mom. Millie Long PIANO UCSF Health Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease academic.oup.com/ibdjournal/art…